Ready to submit? Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window)

Journal overview

Expert Opinion on Therapeutic Targets (ISSN 1472-8222 [print], 1744-7631 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on novel molecular targets, providing expert opinion on the scope for future drug development and the impact on drug discovery.

The journal evaluates molecules, signalling pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and early preclinical studies. Articles should not include clinical information including specific drugs and clinical trials.

The Editors welcome:

  • Reviews covering novel disease targets at the molecular level and information on early preclinical studies and their implications for future drug development.
  • Articles should not include clinical information including specific drugs and clinical trials.
  • Original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs.

The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Authors can choose to publish gold open access in this journal.

Read the Instructions for Authors for information on how to submit your article.

Read full aims and scope

Explore articles

Explore the most recently published articles

Prasanna Anjaneyulu Yakkala et al.
Review Article |
Shan Liu et al.
Review Article |
Jaime Gonzalez-Montero et al.
Editorial |
Free Access
Annarosa Arcangeli et al.
Review Article |
Open Access

Latest issues

Associated journals



Journal news & offers

Editorial Board Members needed for Expert Opinion on Therapeutic Targets - apply nowDiscuss your submission with the Commissioning Editor, Ryan Gilroy